Concepts (190)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Gastrointestinal Microbiome | 5 | 2018 | 1961 | 1.17 | Why? |
| Colon | 3 | 2018 | 669 | 1.07 | Why? |
| Colonic Polyps | 3 | 2018 | 117 | 0.91 | Why? |
| Digestive System | 1 | 2020 | 110 | 0.79 | Why? |
| Gastritis | 1 | 2019 | 66 | 0.77 | Why? |
| Oncogenes | 1 | 2017 | 23 | 0.69 | Why? |
| Genes, Tumor Suppressor | 1 | 2017 | 43 | 0.68 | Why? |
| Plasminogen Activator Inhibitor 1 | 1 | 2018 | 162 | 0.68 | Why? |
| Gene Amplification | 1 | 2017 | 85 | 0.67 | Why? |
| Cell Transformation, Neoplastic | 1 | 2017 | 191 | 0.62 | Why? |
| Helicobacter Infections | 1 | 2019 | 216 | 0.62 | Why? |
| Clostridium Infections | 3 | 2018 | 595 | 0.61 | Why? |
| Helicobacter pylori | 1 | 2019 | 262 | 0.60 | Why? |
| Dysbiosis | 2 | 2018 | 685 | 0.58 | Why? |
| Digestive System Diseases | 1 | 2020 | 378 | 0.58 | Why? |
| Colorectal Neoplasms | 2 | 2018 | 1884 | 0.52 | Why? |
| Treatment Failure | 1 | 2019 | 2106 | 0.49 | Why? |
| Metagenomics | 1 | 2018 | 823 | 0.46 | Why? |
| Non-alcoholic Fatty Liver Disease | 2 | 2019 | 907 | 0.46 | Why? |
| Public Opinion | 1 | 2020 | 1165 | 0.41 | Why? |
| Genomics | 2 | 2019 | 3118 | 0.39 | Why? |
| Feces | 3 | 2018 | 4235 | 0.34 | Why? |
| Global Health | 4 | 2021 | 13911 | 0.34 | Why? |
| Bacteremia | 1 | 2018 | 1372 | 0.33 | Why? |
| Gene Expression Regulation, Neoplastic | 3 | 2018 | 1014 | 0.32 | Why? |
| Th17 Cells | 2 | 2021 | 657 | 0.27 | Why? |
| Fecal Microbiota Transplantation | 2 | 2018 | 372 | 0.25 | Why? |
| Hong Kong | 4 | 2020 | 3361 | 0.23 | Why? |
| Autophagy | 2 | 2019 | 960 | 0.23 | Why? |
| Neoplasms | 3 | 2019 | 17251 | 0.22 | Why? |
| Sepsis | 1 | 2018 | 3517 | 0.22 | Why? |
| Patient Compliance | 2 | 2021 | 1468 | 0.22 | Why? |
| Gene Dosage | 2 | 2018 | 101 | 0.21 | Why? |
| Pandemics | 10 | 2021 | 389249 | 0.20 | Why? |
| Streptococcus gallolyticus | 1 | 2018 | 7 | 0.19 | Why? |
| Bacteroides fragilis | 1 | 2018 | 12 | 0.19 | Why? |
| Pneumonia, Viral | 8 | 2020 | 243684 | 0.18 | Why? |
| Peptidyl-Dipeptidase A | 1 | 2020 | 9659 | 0.18 | Why? |
| Drug Resistance, Bacterial | 2 | 2019 | 1414 | 0.18 | Why? |
| Azoxymethane | 1 | 2017 | 6 | 0.18 | Why? |
| Irritable Bowel Syndrome | 1 | 2021 | 175 | 0.18 | Why? |
| Coronavirus Infections | 8 | 2020 | 253789 | 0.18 | Why? |
| Ribotyping | 1 | 2017 | 54 | 0.18 | Why? |
| Germ-Free Life | 1 | 2017 | 63 | 0.18 | Why? |
| Stilbenes | 1 | 2019 | 113 | 0.17 | Why? |
| Betacoronavirus | 7 | 2020 | 204454 | 0.17 | Why? |
| Masks | 1 | 2020 | 8528 | 0.17 | Why? |
| Ki-67 Antigen | 1 | 2017 | 139 | 0.17 | Why? |
| Brain-Derived Neurotrophic Factor | 1 | 2018 | 133 | 0.17 | Why? |
| Severe Acute Respiratory Syndrome | 2 | 2020 | 12361 | 0.17 | Why? |
| Lymphocytes, Tumor-Infiltrating | 1 | 2017 | 130 | 0.16 | Why? |
| Obesity | 1 | 2018 | 7388 | 0.16 | Why? |
| Colonoscopy | 3 | 2018 | 738 | 0.16 | Why? |
| Protective Agents | 1 | 2019 | 250 | 0.16 | Why? |
| Carcinogenesis | 1 | 2018 | 236 | 0.15 | Why? |
| Epidemiological Monitoring | 2 | 2020 | 3493 | 0.15 | Why? |
| Lysosomes | 1 | 2019 | 416 | 0.15 | Why? |
| Computational Biology | 3 | 2021 | 4514 | 0.15 | Why? |
| Genotyping Techniques | 1 | 2018 | 360 | 0.15 | Why? |
| Cross Infection | 1 | 2017 | 8675 | 0.14 | Why? |
| Glucosides | 1 | 2019 | 359 | 0.14 | Why? |
| Public Health | 1 | 2020 | 16359 | 0.14 | Why? |
| Bacteriophages | 1 | 2017 | 268 | 0.14 | Why? |
| Databases, Nucleic Acid | 1 | 2017 | 272 | 0.14 | Why? |
| Eosinophilia | 1 | 2017 | 292 | 0.14 | Why? |
| Vancomycin | 1 | 2017 | 328 | 0.13 | Why? |
| Pain, Postoperative | 1 | 2018 | 289 | 0.13 | Why? |
| Stomach Neoplasms | 1 | 2019 | 477 | 0.13 | Why? |
| London | 1 | 2020 | 2166 | 0.13 | Why? |
| Humans | 32 | 2021 | 930598 | 0.13 | Why? |
| Hospital Units | 1 | 2020 | 1017 | 0.12 | Why? |
| Anti-Bacterial Agents | 4 | 2019 | 10083 | 0.12 | Why? |
| Disease Transmission, Infectious | 3 | 2021 | 9044 | 0.12 | Why? |
| Mice, Inbred C57BL | 3 | 2019 | 5542 | 0.12 | Why? |
| Neoplasm Proteins | 1 | 2018 | 501 | 0.12 | Why? |
| Disease Models, Animal | 3 | 2019 | 10998 | 0.11 | Why? |
| Th1 Cells | 1 | 2017 | 1228 | 0.11 | Why? |
| Eosinophils | 1 | 2017 | 848 | 0.11 | Why? |
| Recurrence | 2 | 2018 | 3675 | 0.11 | Why? |
| Image Interpretation, Computer-Assisted | 1 | 2016 | 665 | 0.10 | Why? |
| Cell Proliferation | 1 | 2017 | 1973 | 0.10 | Why? |
| Incidence | 4 | 2021 | 25622 | 0.10 | Why? |
| Intestinal Mucosa | 1 | 2017 | 1046 | 0.10 | Why? |
| Odds Ratio | 2 | 2018 | 5861 | 0.10 | Why? |
| Chronic Pain | 1 | 2018 | 736 | 0.10 | Why? |
| Endoscopy, Gastrointestinal | 1 | 2020 | 1545 | 0.09 | Why? |
| Biopsy | 1 | 2018 | 2811 | 0.09 | Why? |
| Biomarkers, Tumor | 1 | 2018 | 1314 | 0.09 | Why? |
| Self Report | 1 | 2021 | 3802 | 0.09 | Why? |
| Animals | 7 | 2019 | 78931 | 0.09 | Why? |
| Guillain-Barre Syndrome | 1 | 2021 | 1495 | 0.09 | Why? |
| Colitis, Ulcerative | 1 | 2017 | 1037 | 0.09 | Why? |
| Carcinoma, Hepatocellular | 1 | 2018 | 1222 | 0.09 | Why? |
| World Health Organization | 1 | 2021 | 4213 | 0.09 | Why? |
| Mutation | 2 | 2018 | 12376 | 0.08 | Why? |
| Aerosols | 2 | 2020 | 5393 | 0.08 | Why? |
| Risk | 1 | 2019 | 5288 | 0.08 | Why? |
| Inflammation Mediators | 1 | 2017 | 2654 | 0.08 | Why? |
| Communicable Diseases, Emerging | 1 | 2020 | 2523 | 0.08 | Why? |
| Liver Neoplasms | 1 | 2018 | 1666 | 0.08 | Why? |
| Bacterial Infections | 1 | 2019 | 2229 | 0.07 | Why? |
| Gastrointestinal Diseases | 1 | 2020 | 2580 | 0.07 | Why? |
| Mortality | 2 | 2021 | 7132 | 0.07 | Why? |
| Community-Acquired Infections | 1 | 2017 | 2328 | 0.07 | Why? |
| Polymorphism, Single Nucleotide | 1 | 2018 | 3607 | 0.07 | Why? |
| Liver Diseases | 1 | 2020 | 2698 | 0.07 | Why? |
| Survival Analysis | 1 | 2017 | 7592 | 0.07 | Why? |
| Patient Admission | 1 | 2020 | 5250 | 0.06 | Why? |
| Health Behavior | 1 | 2020 | 4449 | 0.06 | Why? |
| Aged, 80 and over | 5 | 2018 | 88759 | 0.06 | Why? |
| Adaptation, Psychological | 1 | 2020 | 4996 | 0.06 | Why? |
| B7-2 Antigen | 1 | 2021 | 56 | 0.06 | Why? |
| Interleukin-23 Subunit p19 | 1 | 2021 | 26 | 0.06 | Why? |
| Adult | 8 | 2021 | 244371 | 0.06 | Why? |
| Case-Control Studies | 2 | 2017 | 17671 | 0.06 | Why? |
| Infection Control | 2 | 2020 | 23131 | 0.05 | Why? |
| Communicable Disease Control | 2 | 2021 | 29620 | 0.05 | Why? |
| Biomarkers | 3 | 2018 | 23361 | 0.05 | Why? |
| Prognosis | 3 | 2018 | 32490 | 0.05 | Why? |
| Contact Tracing | 1 | 2020 | 8448 | 0.05 | Why? |
| Pulmonary Disease, Chronic Obstructive | 1 | 2017 | 3832 | 0.05 | Why? |
| Adolescent | 3 | 2020 | 86841 | 0.05 | Why? |
| Male | 10 | 2021 | 367725 | 0.05 | Why? |
| Cross-Sectional Studies | 4 | 2021 | 53120 | 0.05 | Why? |
| Saccharomyces | 1 | 2018 | 5 | 0.05 | Why? |
| Endoscopy | 2 | 2020 | 1564 | 0.05 | Why? |
| Proto-Oncogene Proteins c-vav | 1 | 2018 | 1 | 0.05 | Why? |
| Aurora Kinase A | 1 | 2018 | 7 | 0.05 | Why? |
| Narrow Band Imaging | 1 | 2018 | 24 | 0.05 | Why? |
| Cytokines | 1 | 2021 | 15010 | 0.05 | Why? |
| Middle East Respiratory Syndrome Coronavirus | 1 | 2020 | 8843 | 0.05 | Why? |
| Adenosine Triphosphatases | 1 | 2018 | 78 | 0.04 | Why? |
| Health Knowledge, Attitudes, Practice | 1 | 2021 | 8811 | 0.04 | Why? |
| Telomerase | 1 | 2018 | 45 | 0.04 | Why? |
| Immunologic Techniques | 1 | 2017 | 71 | 0.04 | Why? |
| Prospective Studies | 2 | 2020 | 43301 | 0.04 | Why? |
| Candida albicans | 1 | 2018 | 217 | 0.04 | Why? |
| Host-Pathogen Interactions | 1 | 2017 | 11041 | 0.04 | Why? |
| SARS Virus | 1 | 2020 | 13021 | 0.04 | Why? |
| Middle Aged | 7 | 2021 | 270681 | 0.04 | Why? |
| Female | 9 | 2021 | 380317 | 0.04 | Why? |
| Ubiquitin-Protein Ligases | 1 | 2018 | 249 | 0.04 | Why? |
| Gene Regulatory Networks | 1 | 2021 | 820 | 0.04 | Why? |
| Leukocyte L1 Antigen Complex | 1 | 2017 | 238 | 0.04 | Why? |
| Aspergillus | 1 | 2018 | 347 | 0.04 | Why? |
| Aged | 5 | 2018 | 215776 | 0.04 | Why? |
| RNA, Ribosomal, 16S | 1 | 2018 | 793 | 0.04 | Why? |
| Cell Differentiation | 1 | 2021 | 1338 | 0.03 | Why? |
| Mice | 3 | 2019 | 21357 | 0.03 | Why? |
| Genome, Human | 1 | 2018 | 400 | 0.03 | Why? |
| Wound Healing | 1 | 2017 | 424 | 0.03 | Why? |
| Protein Interaction Maps | 1 | 2021 | 1333 | 0.03 | Why? |
| Signal Transduction | 2 | 2021 | 7207 | 0.03 | Why? |
| Surge Capacity | 1 | 2021 | 894 | 0.03 | Why? |
| Quarantine | 1 | 2020 | 18418 | 0.03 | Why? |
| Retrospective Studies | 3 | 2021 | 105322 | 0.03 | Why? |
| RNA, Viral | 1 | 2020 | 32276 | 0.03 | Why? |
| Young Adult | 2 | 2020 | 93724 | 0.03 | Why? |
| Hemoglobins | 1 | 2017 | 958 | 0.03 | Why? |
| Leukocytes, Mononuclear | 1 | 2021 | 2115 | 0.03 | Why? |
| Singapore | 1 | 2021 | 3641 | 0.03 | Why? |
| Health Personnel | 1 | 2021 | 29646 | 0.03 | Why? |
| Genome-Wide Association Study | 1 | 2018 | 1648 | 0.03 | Why? |
| Respiratory Function Tests | 1 | 2017 | 1755 | 0.03 | Why? |
| RNA-Binding Proteins | 1 | 2018 | 1022 | 0.03 | Why? |
| Delayed Diagnosis | 1 | 2020 | 1529 | 0.03 | Why? |
| Area Under Curve | 1 | 2017 | 2564 | 0.03 | Why? |
| Severity of Illness Index | 1 | 2018 | 48226 | 0.03 | Why? |
| Kaplan-Meier Estimate | 1 | 2018 | 4260 | 0.02 | Why? |
| Internationality | 1 | 2020 | 3297 | 0.02 | Why? |
| Multivariate Analysis | 1 | 2018 | 5440 | 0.02 | Why? |
| Gene Expression Profiling | 1 | 2018 | 3788 | 0.02 | Why? |
| Genotype | 1 | 2018 | 4697 | 0.02 | Why? |
| Proportional Hazards Models | 1 | 2018 | 6543 | 0.02 | Why? |
| ROC Curve | 1 | 2016 | 6024 | 0.02 | Why? |
| Surveys and Questionnaires | 2 | 2021 | 43792 | 0.02 | Why? |
| Genetic Predisposition to Disease | 1 | 2018 | 4027 | 0.02 | Why? |
| Polymerase Chain Reaction | 1 | 2017 | 6740 | 0.02 | Why? |
| Predictive Value of Tests | 1 | 2017 | 9537 | 0.01 | Why? |
| Immunity, Innate | 1 | 2019 | 6570 | 0.01 | Why? |
| Algorithms | 1 | 2018 | 7346 | 0.01 | Why? |
| Treatment Outcome | 2 | 2017 | 51732 | 0.01 | Why? |
| Machine Learning | 1 | 2016 | 4395 | 0.01 | Why? |
| Quality of Life | 1 | 2017 | 9820 | 0.01 | Why? |
| Sensitivity and Specificity | 1 | 2017 | 22971 | 0.01 | Why? |
| Hospital Mortality | 1 | 2020 | 22087 | 0.01 | Why? |
| Practice Guidelines as Topic | 1 | 2020 | 15421 | 0.01 | Why? |
| Cohort Studies | 1 | 2018 | 36005 | 0.01 | Why? |
| Intensive Care Units | 1 | 2020 | 29594 | 0.01 | Why? |
| Risk Factors | 1 | 2021 | 71621 | 0.01 | Why? |
Wong's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(190)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(66)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_